MET and breast cancer: However, molecular and in vivo imaging results clearly indicate that a simple combined blocking of OXPHOS and proton extrusion pumps (MCT4) is not sufficient to fully explain the efficacy of this combined treatment, and further investigations are required to better clarify the mechanisms underlying the synergistic effect of SYRO plus MET in these BC models.